Skip to content

Clinical trials

Phase 1 Lymphoma, B-Cell, Marginal Zone trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell, Marginal Zone Phase: Phase 1 Country / region: Australia Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20211
20222
20233
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting2
Completed2
Recruiting2
Terminated2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie1
BeOne Medicines1
Celgene1
Eli Lilly and Company1
Hutchmed1
Novartis Pharmaceuticals1
Prelude Therapeutics1
Qilu Puget Sound Biotherapeutics (dba Sound Biologics)1
Sana Biotechnology1
Taiho Oncology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell, Marginal Zone10
Lymphoma, Large B-Cell, Diffuse8
Lymphoma, Mantle-Cell8
Lymphoma, Follicular7
Lymphoma, Non-Hodgkin6
Leukemia, Lymphocytic, Chronic, B-Cell5
Waldenstrom Macroglobulinemia4
Lymphoma, B-Cell3
Neoplasms2
Hematologic Neoplasms1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.